Evidence map›Paper›PMID 12670313›Full record

ArticleThe European journal of neuroscience2003

Bidirectional modulation of visual plasticity by cholinergic receptor subtypes in the frog optic tectum.

Chuan-Jiang Yu, Christopher M Butt, Elizabeth A Debski

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 26 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chuan-Jiang YuDepartment of Biology, University of Kentucky, Lexington, Kentucky 40506-0225, USA.
Christopher M Butt
Elizabeth A Debski
University of Kentucky · US

Funding

CHOLINERGIC MODULATION OF THE VISUAL SYSTEMR01EY011913 · NEI · UNIVERSITY OF KENTUCKY · PI DEBSKI, ELIZABETH A · 1997 to 2000
$91k
NEI NIH HHS EY11913NEI NIH HHS R01 EY011913
6 · The paper itself

Abstract

Cholinergic input to the optic tectum is necessary for visual map maintenance. To understand why, we examined the effects of activation of the different cholinergic receptor subtypes in tectal brain slices and determined whether the retinotectal map was affected by manipulations of their activity in vivo. Both alpha-bungarotoxin sensitive and insensitive nicotinic receptor agonists increased spontaneous postsynaptic currents (sPSCs) in a subpopulation of patch-clamped tectal cells; application of subtype selective receptor antagonists reduced nicotine-induced increases in sPSCs. Activation of alpha-bungarotoxin insensitive nicotinic receptors also induced substantial inward current in some cells. Muscarinic receptor mediated outward current responses were blocked by the M2-like muscarinic receptor antagonists himbacine or AF-DX 384 and mimicked by application of the M2-like agonist oxotremorine. A less frequently observed muscarinic response involving a change in sPSC frequency appeared to be mediated by M1-like muscarinic receptors. In separate experiments, pharmacological manipulation of cholinergic receptor subtype activation led to changes in the activity-dependent visual map created in the tectum by retinal ganglion cell terminals. Chronic exposure of the tectum to either alpha-bungarotoxin insensitive, alpha-bungarotoxin sensitive or M1-like receptor antagonists resulted in map disruption. However, treatment with the M2-like receptor antagonist, AF-DX 384, compressed the map. We conclude that nicotinic or M1-like muscarinic receptors control input to tectal cells while alpha-bungarotoxin insensitive nicotinic receptors and M2-like muscarinic receptors change tectal cell responses to that input. Blockade of the different cholinergic receptor subtypes can have opposing effects on map topography that are consistent with expected effects on tectal cell activity levels.

Indexed as

AcetylcholineAnimalsBungarotoxinsCholinergic AgonistsCholinergic AntagonistsCholinergic FibersElectrophysiologyPatch-Clamp TechniquesRana pipiensReceptor, Muscarinic M1Receptor, Muscarinic M2Receptors, CholinergicReceptors, MuscarinicReceptors, NicotinicRetinaSuperior ColliculiAcetylcholineBungarotoxinsCholinergic AgonistsCholinergic AntagonistsReceptor, Muscarinic M1Receptor, Muscarinic M2Receptors, CholinergicReceptors, MuscarinicReceptors, Nicotinic

Identifiers

PMID12670313
PMCPMC2267905
OpenAlexW2066970978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.